clopidogrel

purinergic receptor P2Y12 ; Homo sapiens







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31965164 Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries. 2021 Mar 15 1
2 31766967 microRNA-605 rs2043556 polymorphisms affect clopidogrel therapy through modulation of CYP2B6 and P2RY12 in acute coronary syndrome patients. 2020 Oct 2 3
3 31912949 One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry. 2020 Jun 2
4 31980270 Patient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain-MI Registry. 2020 Apr 1 1
5 32006144 Efficacy and Safety of Potent Oral P2Y12 Inhibitors in Medically Managed ACS Patients: a Meta-analysis. 2020 Apr 1
6 31591378 ADP secreted by dying melanoma cells mediates chemotaxis and chemokine secretion of macrophages via the purinergic receptor P2Y12. 2019 Oct 7 1
7 31660309 Targeting ticagrelor: a novel therapy for emergency reversal. 2019 Sep 1
8 31753208 P2Y12 Inhibition by Clopidogrel Increases Periprocedural Bleeds in Patients Undergoing Transcatheter Aortic Valve Replacement. 2019 Nov 26 1
9 31850373 Stratified Approaches to Antiplatelet Therapies Based on Platelet Reactivity Testing. 2019 2